Comparison of 60 or 90 mg/m2 of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics

被引：16

作者：

Devillier, Raynier ^{[1
,2
]}

Bertoli, Sarah ^{[3
]}

Prebet, Thomas ^{[1
]}

Huguet, Francoise ^{[3
]}

Etienne, Anne ^{[1
]}

Charbonnier, Aude ^{[1
]}

Rey, Jerome ^{[1
]}

Delabesse, Eric ^{[3
,4
]}

D'Incan, Evelyne ^{[1
]}

Huynh, Anne ^{[3
]}

Blaise, Didier ^{[1
,4
]}

Recher, Christian ^{[3
,4
]}

Vey, Norbert ^{[1
,2
]}

机构：

[1] Inst J Paoli I Calmettes, Dept Hematol, F-13009 Marseille, France

[2] Aix Marseille Univ, Fac Med, Marseille, France

[3] Inst Univ Canc Toulouse Oncopole, Dept Hematol, F-31059 Toulouse 9, France

[4] Toulouse Univ, Fac Med, Toulouse, France

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2015年 / 90卷 / 02期

关键词：

ANTHRACYCLINE DOSE INTENSIFICATION; YOUNGER PATIENTS; IDARUBICIN; REMISSION; IMPACT; TRIAL; AML;

D O I：

10.1002/ajh.23884

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E29 / E30

页数：2

共 13 条

[1] Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group [J].

Bertoli, Sarah ;

Bories, Pierre ;

Bene, Marie C. ;

Daliphard, Sylvie ;

Lioure, Bruno ;

Pigneux, Arnaud ;

Vey, Norbert ;

Delaunay, Jacques ;

Leymarie, Vincent ;

Luquet, Isabelle ;

Blanchet, Odile ;

Cornillet-Lefebvre, Pascale ;

Hunault, Mathilde ;

Bouscary, Didier ;

Fegueux, Nathalie ;

Guardiola, Philippe ;

Dreyfus, Francois ;

Harousseau, Jean Luc ;

Cahn, Jean Yves ;

Ifrah, Norbert ;

Recher, Christian .

HAEMATOLOGICA, 2014, 99 (01) :46-53

[2] Treatment of acute myeloid leukemia: are we making progress? [J].

Burnett, Alan K. .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2012, :1-6

[3] Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia [J].

Cheson, BD ;

Bennett, JM ;

Kopecky, KJ ;

Büchner, T ;

Willman, CL ;

Estey, EH ;

Schiffer, CA ;

Döhner, H ;

Tallman, MS ;

Lister, TA ;

LoCocco, F ;

Willemze, R ;

Biondi, A ;

Hiddemann, W ;

Larson, RA ;

Löwenberg, B ;

Sanz, MA ;

Head, DR ;

Ohno, R ;

Bloomfield, CD .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4642-4649

[4] Anthracycline Dose Intensification in Acute Myeloid Leukemia [J].

Fernandez, Hugo F. ;

Sun, Zhuoxin ;

Yao, Xiaopan ;

Litzow, Mark R. ;

Luger, Selina M. ;

Paietta, Elisabeth M. ;

Racevskis, Janis ;

Dewald, Gordon W. ;

Ketterling, Rhett P. ;

Bennett, John M. ;

Rowe, Jacob M. ;

Lazarus, Hillard M. ;

Tallman, Martin S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1249-1259

[5] Impact of FLT3 ITD/NPM1 mutation status in adult patients with acute myelocytic leukemia autografted in first remission [J].

Gorin, Norbert-Claude ;

Labopin, Myriam ;

Meloni, Giovanna ;

Pigneux, Arnaud ;

Esteve, Jordi ;

Mohty, Mohamad .

HAEMATOLOGICA, 2013, 98 (02) :E12-E14

[6]

LaRochelle O, 2011, ONCOTARGET, V2, P850

[7] High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia [J].

Lowenberg, Bob ;

Ossenkoppele, Gert J. ;

van Putten, Wim ;

Schouten, Harry C. ;

Graux, Carlos ;

Ferrant, Augustin ;

Sonneveld, Pieter ;

Maertens, Johan ;

Jongen-Lavrencic, Mojca ;

von Lilienfeld-Toal, Marie ;

Biemond, Bart J. ;

Vellenga, Edo ;

Kooy, Marinus van Marwijk ;

Verdonck, Leo F. ;

Beck, Joachim ;

Doehner, Hartmut ;

Gratwohl, Alois ;

Pabst, Thomas ;

Verhoef, Gregor .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1235-1248

[8] Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson [J].

Othus, M. ;

Kantarjian, H. ;

Petersdorf, S. ;

Ravandi, F. ;

Godwin, J. ;

Cortes, J. ;

Pierce, S. ;

Erba, H. ;

Faderl, S. ;

Appelbaum, F. R. ;

Estey, E. .

LEUKEMIA, 2014, 28 (02) :289-292

[9] Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia [J].

Patel, Jay P. ;

Goenen, Mithat ;

Figueroa, Maria E. ;

Fernandez, Hugo ;

Sun, Zhuoxin ;

Racevskis, Janis ;

Van Vlierberghe, Pieter ;

Dolgalev, Igor ;

Thomas, Sabrena ;

Aminova, Olga ;

Huberman, Kety ;

Cheng, Janice ;

Viale, Agnes ;

Socci, Nicholas D. ;

Heguy, Adriana ;

Cherry, Athena ;

Vance, Gail ;

Higgins, Rodney R. ;

Ketterling, Rhett P. ;

Gallagher, Robert E. ;

Litzow, Mark ;

van den Brink, Marcel R. M. ;

Lazarus, Hillard M. ;

Rowe, Jacob M. ;

Luger, Selina ;

Ferrando, Adolfo ;

Paietta, Elisabeth ;

Tallman, Martin S. ;

Melnick, Ari ;

Abdel-Wahab, Omar ;

Levine, Ross L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (12) :1079-1089

[10] Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia [J].

Prebet, Thomas ;

Bertoli, Sarah ;

Delaunay, Jacques ;

Pigneux, Arnaud ;

Delabesse, Eric ;

Mozziconacci, Marie Joelle ;

Bidet, Audrey ;

Recher, Christian ;

Vey, Norbert .

HAEMATOLOGICA, 2014, 99 (10) :E185-E187

← 1 2 →